Weekly Spotlight - 31.10.24

In the News

Liver Disease Misdiagnosed as Menopause: A Patient's Journey

Doctors initially mistook Gill Rich's rare liver disease for menopause, leading to years of misdiagnosis. Both she and Wendy Wheat, who faced similar challenges, found solace in a support group. Now, a new pill, Elafibranor, offers hope by improving liver function for those with primary biliary cholangitis.

SuSiE Method Outperforms Others in PBC Genetic Variant Detection

SuSiE takes the crown in the genetic detective game, outshining h2-D2 and FINEMAP in pinpointing PBC's genetic culprits. While FINEMAP found 29 out of 57, SuSiE's precision and power make it the star. This could lead to better treatments, proving science can be fun and effective!

NICE Approves Iqirvo for Treating Rare Liver Disease in the UK

Ipsen's Iqirvo, a new liver disease drug, gets a thumbs-up from NICE for treating primary biliary cholangitis. It's the first NHS-approved PBC treatment in a decade! Iqirvo works wonders with UDCA or solo, tackling symptoms like itch and fatigue. Cheers to better liver health!

Brighton Woman Shares Struggles with Rare Autoimmune Liver Disease

Michelle Williams from Brighton shares her battle with primary biliary cholangitis, a rare liver disease causing severe itching and fatigue. Diagnosed after years of symptoms, she now volunteers for the PBC Foundation. Despite treatment challenges, she remains hopeful with new NHS-approved medication, aiming to raise awareness.

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!